Arutunyan, Belinda V.
Koltsova, Ekaterina M.
Shpilyuk, Margarita A.
Lipets, Elena N.
Timofeeva, Leila A.
Karavaeva, Anna L.
Balashova, Ekaterina N.
Krechetova, Liubov V.
Ataullakhanov, Fazoil I.
Zubkov, Viktor V.
Degtyarev, Dmitry N.
Sukhikh, Gennady T.
Tetruashvili, Nana K.
Balandina, Anna N.
Article History
Received: 31 January 2024
Revised: 6 July 2024
Accepted: 5 August 2024
First Online: 17 August 2024
Competing interests
: FIA is a former employee and cofounder of Hemacore, LLC. Hemacore LLC holds several patents and patent applications related to the diagnostic use of spatial clot growth and has developed the assay under the trade name Thrombodynamics®. Hemacore LLC did not have any additional role in the design of the study, collection and analysis of the data, or the decision to publish or prepare the manuscript. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results. All other authors declare no competing financial interests.
: The study was conducted in accordance with the Declaration of Helsinki and approved by the ethics committee of the National Medical Research Center for Obstetrics, Gynecology and Perinatology named after academician Kulakov V.I. (Protocol code: 10, date of approval: 23 November 2017).
: Written informed consent was obtained from the legal representatives (parents) of the newborns to publish this paper.